Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Water Works Company, Inc.AWK · Entity 3169 | Vice President and Treasurer | February 14, 2018 | February 16, 2018 |
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | VP & Treasurer | February 20, 2026 | February 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Water Works Company, Inc.
Report date February 14, 2018 · Filed February 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 586 |
Reported balance
After 2018-02-14 transaction · row 1
1 source rowRow 1 · 2018-02-14 · Grant · Acquired 484 · Balance 586 |
WEST PHARMACEUTICAL SERVICES INC
Report date February 20, 2026 · Filed February 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,407.897 |
Ending reported balance
After 2026-02-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-20 · Exercise / conversion · Acquired 60.22 · Balance 1,429.966 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2026-02-20 · Tax withholding · Disposed 22.069 · Balance 1,407.897 |
| Rst. Stock UnitSEC Table II · derivative / convertible security | Direct | 177.644 |
Reported balance
After 2026-02-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-20 · Exercise / conversion · Disposed 60.22 · Balance 177.644 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 23, 2026 22:41 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionRst. Stock Unit · Derivative | 60.22 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000024 · form4.xml · derivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177.644 Underlying: Common Stock · 60.22 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year. F2 · derivative.expiration_date: On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 22:41 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 22.069 | $241.12 | $5,321.28 |
DisclosureSEC source: 0000105770-26-000024 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,407.897 Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 22:41 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 60.22 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000105770-26-000024 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,429.966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:04 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 41.519 | $243.19 | $10,097.01 |
DisclosureSEC source: 0000105770-26-000019 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,369.746 Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:04 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 115.91 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000019 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,411.265 F1 · shares: These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantRst. Stock Unit · Derivative | 237 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006117 · form4.xml · derivative · entry 4 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237 Underlying: Common Stock · 237 shares Expires not disclosed F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026. F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Option (Right to Buy) · Derivative | 548 | $0.00 Strike: $211.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006117 · form4.xml · derivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548 Underlying: Common Stock · 548 shares Expires 2035-02-18 F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 23.492 | $211.00 | $4,956.81 |
DisclosureSEC source: 0001127602-25-006117 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,295.355 Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 65.706 | $211.00 | $13,863.97 |
DisclosureSEC source: 0001127602-25-006117 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,318.847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 16:05 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 478 | $0.00 Strike: $173.22 | $0.00 |
DisclosureSEC source: 0001127602-24-026141 · form4.xml · derivative · entry 4 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Stock Options (Right to Buy) · 478 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vested in four equal annual installments beginning on February 18, 2021. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 16:05 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 225 | $310.40 | $69,840.00 |
DisclosureSEC source: 0001127602-24-026141 · form4.xml · nonDerivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253.141 Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 16:05 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 478 | $310.40 | $148,371.20 |
DisclosureSEC source: 0001127602-24-026141 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,478.141 Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 16:05 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 478 | $173.22 | $82,799.16 |
DisclosureSEC source: 0001127602-24-026141 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,956.141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 21:02 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 529 | $0.00 Strike: $102.51 | $0.00 |
DisclosureSEC source: 0001127602-24-022725 · form4.xml · derivative · entry 4 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Stock Options (Right to Buy) · 529 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vested in four equal annual installments beginning on February 19, 2020. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 21:02 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 500 | $300.00 | $150,000.00 |
DisclosureSEC source: 0001127602-24-022725 · form4.xml · nonDerivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,478.141 Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 21:02 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 529 | $300.00 | $158,700.00 |
DisclosureSEC source: 0001127602-24-022725 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,978.141 Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 21:02 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 529 | $102.51 | $54,227.79 |
DisclosureSEC source: 0001127602-24-022725 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,507.141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 18:07 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,019 | $0.00 Strike: $102.51 | $0.00 |
DisclosureSEC source: 0001127602-24-007734 · form4.xml · derivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529 Underlying: Stock Options (Right to Buy) · 2,019 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 19, 2020. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 18:07 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,019 | $358.62 | $724,061.45 |
DisclosureSEC source: 0001127602-24-007734 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,979.091 Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 18:07 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,019 | $102.51 | $206,967.69 |
DisclosureSEC source: 0001127602-24-007734 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,998.091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:50 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to Buy) · Derivative | 742 | $0.00 Strike: $350.18 | $0.00 |
DisclosureSEC source: 0001127602-24-006415 · form4.xml · derivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 742 Underlying: Stock Options (Right to Buy) · 742 shares Expires 2034-02-20 F2 · derivative.exercise_date: This grant vests in four equal installments beginning on February 20, 2025. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:50 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 144 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006415 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,979.091 F1 · security: 2021 PSUs (PP20) award vesting net of taxes withheld. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 596 | $0.00 Strike: $274.29 | $0.00 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · derivative · entry 6 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 596 Underlying: Stock Options (Right to Buy) · 596 shares Expires 2031-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 23, 2022. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 594 | $0.00 Strike: $173.22 | $0.00 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · derivative · entry 5 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478 Underlying: Stock Options (Right to Buy) · 594 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 18, 2021. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 596 | $322.27 | $192,072.92 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · nonDerivative · entry 4 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,835.091 Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 594 | $322.48 | $191,550.15 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · nonDerivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,431.091 Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 596 | $274.29 | $163,476.84 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,025.091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 17:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 594 | $173.22 | $102,892.68 |
DisclosureSEC source: 0001127602-23-026551 · form4.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,429.091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 840 | $0.00 Strike: $102.51 | $0.00 |
DisclosureSEC source: 0001562180-23-006299 · primarydocument.xml · derivative · entry 5 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 708 Underlying: Common Stock · 840 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 840 | $0.00 Strike: $173.22 | $0.00 |
DisclosureSEC source: 0001562180-23-006299 · primarydocument.xml · derivative · entry 4 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,072 Underlying: Common Stock · 840 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 1,680 | $396.54 | $666,187.20 |
DisclosureSEC source: 0001562180-23-006299 · primarydocument.xml · nonDerivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,829.4979 Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 840 | $173.22 | $145,504.80 |
DisclosureSEC source: 0001562180-23-006299 · primarydocument.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,509.4979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:52 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 840 | $102.51 | $86,108.40 |
DisclosureSEC source: 0001562180-23-006299 · primarydocument.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,669.4979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2023 Filed May 31, 2023 20:38 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 1,000 | $0.00 Strike: $102.51 | $0.00 |
DisclosureSEC source: 0001562180-23-004627 · primarydocument.xml · derivative · entry 3 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,548 Underlying: Common Stock · 1,000 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2023 Filed May 31, 2023 20:38 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 1,000 | $343.05 | $343,050.00 |
DisclosureSEC source: 0001562180-23-004627 · primarydocument.xml · nonDerivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,829.4979 Read SEC document |
| May 30, 2023 Filed May 31, 2023 20:38 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 1,000 | $102.51 | $102,510.00 |
DisclosureSEC source: 0001562180-23-004627 · primarydocument.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,829.4979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:29 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 780 | $0.00 Strike: $306.68 | $0.00 |
DisclosureSEC source: 0001562180-23-001797 · primarydocument.xml · derivative · entry 2 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780 Underlying: Stock Options (Right to Buy) · 780 shares Expires 2033-02-21 F2 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 21, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:29 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 407 | $306.68 | $124,818.76 |
DisclosureSEC source: 0001562180-23-001797 · primarydocument.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · VP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,829.4979 F1 · shares: 2020 PSUs (PP19) award vesting net of taxes withheld Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 19:12 UTC | American Water Works Company, Inc. AWK · Entity 3169 | GrantCommon Stock | 484 | $0.00 | $0.00 |
DisclosureSEC source: 0001410636-18-000071 · wf-form4_151882634289184.xml · nonDerivative · entry 1 Witherspoon Charles · CIK 0001731739 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.